Title:
複素環式化合物およびその使用
Document Type and Number:
Japanese Patent JP6978003
Kind Code:
B2
Abstract:
Compounds having the general formula (I) and pharmaceutical compositions that can be used as Bruton's Tyrosine Kinase (BTK), ITK, JAK3, and selective mutant epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitor and their uses in the treatment of related diseases and disorders such as cancer.
Inventors:
Jai, Hai Xiao
Woo, fan
Woo, gangui
Woo, fan
Woo, gangui
Application Number:
JP2018529028A
Publication Date:
December 08, 2021
Filing Date:
December 02, 2016
Export Citation:
Assignee:
Cho Tian Tian Feng-Yen Biotechnology Company Limited
International Classes:
C07D495/04; A61K31/519; A61K31/5377; A61P35/00; A61P35/02; A61P43/00
Domestic Patent References:
| JP2013544273A | ||||
| JP2018535980A | ||||
| JP2013529630A | ||||
| JP2005523251A | ||||
| JP2004517898A |
Foreign References:
| WO2011140338A1 | ||||
| WO2016011979A1 | ||||
| WO2007084815A2 |
Other References:
Eman Z. Elrazaz et al.,Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents,Future Journal of Pharmaceutical Sciences,2015年,1,pp. 33-41
Attorney, Agent or Firm:
Longhua International Patent Service Corporation
Previous Patent: Thieno-pyrimidine derivatives and their use
Next Patent: Network mapping in a content delivery network
Next Patent: Network mapping in a content delivery network